Effectiveness of three calcitonin gene-related peptide monoclonal antibodies for migraine: A 12-month, single-center, observational real-world study in Japan

Keisuke Suzuki(NEC (Japan)), Koichi Hirata(Japan Coal Energy Center), Yasuo Haruyama(Dokkyo Medical University), Tomohiko Shiina(Dokkyo Medical University), Shiho Suzuki(Dokkyo University), Muneto Tatsumoto(Dokkyo Medical University), Hiroaki Fujita(Dokkyo Medical University)
Cephalalgia
May 1, 2023
Cited by 53


Related Papers